Anti-KCNJ18 antibodies are used in the immunodetection of the protein potassium inwardly rectifying channel subfamily J member 18. In humans, the canonical protein has a reported length of 433 amino acid residues and a mass of 48.9 kDa. Its subcellular localization is in the cell membrane. It is notably expressed in skeletal muscle. A member of the Inward rectifier-type potassium channel (TC 1.A.2.1) protein family, KCNJ18 is known to be involved with the transport of ions. Post-translational modifications have been described, including phosphorylation. The KCNJ18 gene has been associated with the disease, Thyrotoxic periodic paralysis. Synonyms for this target antigen include inward rectifier K(+) channel Kir2.6, inwardly rectifying potassium channel 18, potassium channel, inwardly rectifying subfamily J, member 18, and inward rectifier potassium channel 18. Western Blot is a widely used application for the KCNJ18 antibodies listed below. In addition, ELISA is also a common application.